ArticleScientific reports2025
Microsecond pulsed electric fields induce myocardial ablation by secondary mitochondrial damage and cell death mechanisms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mechanistic insights into a novel GPX4 inhibitor Compound AI-3p reversing cisplatin-resistance in ovarian cancer cells.Journal of ovarian research · 2026Article
- Nanosecond Pulsed Electric Fields (nsPEFs) for Precision Intracellular Oncotherapy: Recent Advances and Emerging Directions.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Microsecond pulsed electric field (µsPEF) is a newer treatment modality to replace catheter ablation treatment of Atrial fibrillation (AF) due to its fewer side effects. This study aims to find out experimental parameters that effectively induce cardiomyocyte death and the precise mechanisms for microsecond pulsed electric fields (µsPEFs) ablation of cardiomyocytes. CCK8 and flow apoptosis analysis were employed to examine the effects of different µsPEFs on cardiomyocytes in vitro. The mechanisms by which the µsPEFs ablation works were explored through a combination of transcriptome study, transmission electron microscope (TEM) observation of mitochondria, pathway enrichment analysis, and interaction network analysis. In vivo experiments on mice involving HE, Masson, TUNEL and Immunofluorescence staining examinations were conducted to confirm the in vitro experimental results. When more than 30 pulses were applied, a continuous decline in post-ablation relative cell activity was observed, decreasing from 0.36 at 3 h to 0.13 (p < 0.01) at 48 h. Notably, at a voltage of 1500 V/cm and a pulse count of 50, the apoptosis rate exceeded 95%, coupled with a more stable and consistent cell ablation. Following ablation, a notable upregulation in mitochondria-related transcription levels was observed, accompanied by mitochondrial membrane disruption and an increase in Cytochrome C levels. Within a certain range, an increase in voltage and number of electric pulses corresponded to a greater quantity of cell mortality in the ablation zone. The µsPEFs induced cell injury by impairing mitochondrial function and potentially triggering the mitochondrial apoptosis pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.